Two mechanisms of soluble CD4 (sCD4)-mediated inhibition of human immunodeficiency virus type 1 (HIV-1) infectivity and their relation to primary HIV-1 isolates with reduced sensitivity to sCD4
Explore this paper's citation graph
Summary
Experiments in which sCD4, HIV-1, and cell concentrations and sequence of combination, noninfectious/infectious particle ratio, and temperature were varied produced results that support the conclusion that s CD4 inhibits HIV- 1 infection by two mechanisms: reversible blockage of receptor binding and irreversible inactivation of infectivity.
- Type
- article
- Published
- 1993-03-01
- Cited by
- 97
- References
- 42
- Access
- Open access
- OpenAlex
- https://openalex.org/W1928433960
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:24095514
Keywords
Infectivity, Biology, Avidity, Virology, Receptor
References
- Blocking of human immunodeficiency virus infection depends on cell density and viral stock age
- Kinetics of soluble CD4 binding to cells expressing human immunodeficiency virus type 1 envelope glycoprotein
- Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen.
- In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV).
- Recombinant CD4-selected human immunodeficiency virus type 1 variants with reduced gp120 affinity for CD4 and increased cell fusion capacity
- Penetration of CD4 T cells by HIV-1. The CD4 receptor does not internalize with HIV, and CD4-related signal transduction events are not required for entry.
- A region in domain 1 of CD4 distinct from the primary gp120 binding site is involved in HIV infection and virus-mediated fusion.
- Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone
- Mapping genetic determinants for human immunodeficiency virus type 1 resistance to soluble CD4
- Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry.
- Envelope glycoproteins from biologically diverse isolates of immunodeficiency viruses have widely different affinities for CD4.
- Kinetics of HIV-1 interactions with sCD4 and CD4+ cells: implications for inhibition of virus infection and initial steps of virus entry into cells.
- Envelope proteins from clinical isolates of human immunodeficiency virus type 1 that are refractory to neutralization by soluble CD4 possess high affinity for the CD4 receptor.
- Dissociation of gp120 from HIV-1 virions induced by soluble CD4.
- High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates.
- Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule.
- Synergism between HIV gp120 and gp120-specific antibody in blocking human T cell activation.
- Stimulation of glycoprotein gp120 dissociation from the envelope glycoprotein complex of human immunodeficiency virus type 1 by soluble CD4 and CD4 peptide derivatives: implications for the role of the complementarity-determining region 3-like region in membrane fusion.
- soluble form of CD4 (T4) protein inhibits AIDS virus infection
- Immunoassay for the detection and quantitation of infectious human retrovirus, lymphadenopathy-associated virus (LAV).
Cited by
- Differences in CD4 dependence for infectivity of laboratory-adapted and primary patient isolates of human immunodeficiency virus type 1
- Membrane fusion mediated by human immunodeficiency virus envelope glycoprotein.
- A Mutation in the Human Immunodeficiency Virus Type 1 Gag Protein Destabilizes the Interaction of the Envelope Protein Subunits gp120 and gp41
- AIDS and HIV infection.
- The receptor for HIV: dissection of CD4 and studies on putative accessory factors.
- Molecular and Cell Biology of Human Gene Therapeutics
- Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization
- Antibody mediated neutralization and enhancement of HIV-1 infection
- Anti-HIV-1 activity of cellulose acetate phthalate: Synergy with soluble CD4 and induction of "dead-end" gp41 six-helix bundles
- Increase in soluble CD4 binding to and CD4-induced dissociation of gp120 from virions correlates with infectivity of human immunodeficiency virus type 1
- Production and Characterization of a Soluble, Active Form of Tva, the Subgroup A Avian Sarcoma and Leukosis Virus Receptor
- Soluble Forms of the Subgroup A Avian Leukosis Virus [ALV(A)] Receptor Tva Significantly Inhibit ALV(A) Infection In Vitro and In Vivo
- Macrophage-tropic and T-cell line-adapted chimeric strains of human immunodeficiency virus type 1 differ in their susceptibilities to neutralization by soluble CD4 at different temperatures
- Insertion of primary syncytium-inducing (SI) and non-SI envelope V3 loops in human immunodeficiency virus type 1 (HIV-1) LAI reduces neutralization sensitivity to autologous, but not heterologous, HIV-1 antibodies
- Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes
- Humoral response to oligomeric human immunodeficiency virus type 1 envelope protein
- Effective ex vivo neutralization of human immunodeficiency virus type 1 in plasma by recombinant immunoglobulin molecules
- HIV‐1 entry and reverse transcription in macrophages
- Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates
- Differential regulation of cellular tropism and sensitivity to soluble CD4 neutralization by the envelope gp120 of human immunodeficiency virus type 1
Related papers
- Theileria parva: In Vitro Studies on the Effects of Holding Temperature, pH and Medium on Sporozoite Infectivity
- A direct relationship between the partitioning of the pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the purification of plasma proteins
- Effect of Exposure to the Atmosphere on the Infectivity of Group A Streptococci
- SOME EFFECTS OF HYDROGEN ION CONCENTRATION ON TRYPANOSOME NUMBERS AND INFECTIVITY.
- Infectivity for mice of Trypanosoma cruzi I and II strains isolated from different hosts
- Effect of Various Additives on Long-term Preservation of Tomato Spotted Wilt Virus
- Optimized Infectivity of the Cell-Free Single-Cycle Human Immunodeficiency Viruses Type 1 (HIV-1) and Its Restriction by Host Cells
- Stability and infectivity of novel pandemic influenza A (H1N1) virus in blood-derived matrices under different storage conditions
- Interaction of Respiratory Syncytial Virus with Polyions